Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Join Barchart Premier for advanced OPTIONS screeners and volatility tools. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or

Catalyst Pharm Inc (CPRX)

Catalyst Pharm Inc (CPRX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
News & Headlines for [[ item.sessionDateDisplayLong ]]
Catalyst Pharmaceuticals to Participate in Upcoming Investor Conferences

CPRX : 20.97 (-0.85%)
Catalyst Pharmaceuticals Recognized Among BioSpace 2025 Best Places to Work

CPRX : 20.97 (-0.85%)
Zacks Industry Outlook Madrigal, Corcept, Catalyst Larimar and Theravance

For Immediate ReleaseChicago, IL – November 11, 2024 – Today, Zacks Equity Research like Madrigal Pharmaceuticals MDGL, Corcept Therapeutics CORT, Catalyst Pharmaceuticals CPRX, Larimar Therapeutics...

CORT : 56.45 (+0.64%)
TBPH : 9.84 (-1.30%)
MDGL : 321.03 (+1.24%)
LRMR : 5.82 (-4.28%)
CPRX : 20.97 (-0.85%)
5 Small Drug Stocks to Buy as Trump Gets Re-Elected

The drug industry witnessed major policy changes during Joe Biden's four-year term as U.S. President, including the historic Inflation Reduction Act (“IRA”). With Donald Trump’s reelection, the biotech...

CORT : 56.45 (+0.64%)
TBPH : 9.84 (-1.30%)
MDGL : 321.03 (+1.24%)
LRMR : 5.82 (-4.28%)
CPRX : 20.97 (-0.85%)
Catalyst Pharmaceuticals Reports Strong Third Quarter 2024 Financial Results and Provides Corporate Update

CPRX : 20.97 (-0.85%)
Catalyst Pharmaceuticals to Report Third Quarter 2024 Financial Results on November 6, 2024

CPRX : 20.97 (-0.85%)
SRRK Stock Soars as Muscle Disease Drug Meets Phase III Study Goal

Shares of Scholar Rock SRRK skyrocketed 362% on Monday after the company announced positive top-line results from the late-stage study, evaluating the efficacy and safety of its investigational muscle-targeted...

BHVN : 45.24 (-3.40%)
ANIP : 54.75 (-0.64%)
CPRX : 20.97 (-0.85%)
SRRK : 27.25 (-2.19%)
Catalyst Pharmaceuticals Donates $100,000 to the American Red Cross Hurricane Helene Relief Efforts

CPRX : 20.97 (-0.85%)
New Strong Buy Stocks for October 8th

Here are five stocks added to the Zacks Rank #1 (Strong Buy) List today:Catalyst Pharmaceuticals CPRX: This commercial-stage biopharmaceutical company which is focused on the development and commercialization...

CRUS : 100.53 (+0.32%)
CRAI : 191.23 (-0.72%)
CPRX : 20.97 (-0.85%)
DXC : 21.25 (+0.38%)
HCI : 108.13 (+0.12%)
2 Incredible Growth Stocks to Buy Hand Over Fist Right Now

These two healthcare stocks may be deeply undervalued.

ETN : 369.02 (+2.37%)
CPRX : 20.97 (-0.85%)
NVAX : 7.97 (-1.12%)
SNY : 47.69 (-0.19%)

Barchart Exclusives

Should You Buy This Nuclear Energy Stock Under $10?
ASP Isotopes is a nuclear energy stock priced under $10 that is positioned to deliver outsized gains to shareholders in the upcoming decade. Read more
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.

Free Barchart Webinar